View Item 

Show simple item record

Novel Peptide Ligands of RGS4 from a Focused One-Bead, One-Compound Library
dc.contributor.authorRoof, Rebecca A.en_US
dc.contributor.authorSobczyk-Kojiro, Katarzynaen_US
dc.contributor.authorTurbiak, Anjanette J.en_US
dc.contributor.authorRoman, David L.en_US
dc.contributor.authorPogozheva, Irina D.en_US
dc.contributor.authorBlazer, Levi L.en_US
dc.contributor.authorNeubig, Richard R.en_US
dc.contributor.authorMosberg, Henry I.en_US
dc.date.accessioned2010-04-01T15:08:22Z
dc.date.available2010-04-01T15:08:22Z
dc.date.issued2008-08en_US
dc.identifier.citationRoof, Rebecca A.; Sobczyk-Kojiro, Katarzyna; Turbiak, Anjanette J.; Roman, David L.; Pogozheva, Irina D.; Blazer, Levi L.; Neubig, Richard R.; Mosberg, Henry I. (2008). "Novel Peptide Ligands of RGS4 from a Focused One-Bead, One-Compound Library." Chemical Biology & Drug Design 72(2): 111-119. <http://hdl.handle.net/2027.42/65605>en_US
dc.identifier.issn1747-0277en_US
dc.identifier.issn1747-0285en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/65605
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18637987&dopt=citationen_US
dc.format.extent378217 bytes
dc.format.extent3110 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rightsJournal compilation © 2008 Blackwell Munksgaarden_US
dc.subject.otherFocused Libraryen_US
dc.subject.otherOne-bead One-compound Libraryen_US
dc.subject.otherProtein–Protein Interaction Inhibitorsen_US
dc.subject.otherRegulators of G-protein Signalingen_US
dc.subject.otherStructure–Activity Relationshipen_US
dc.titleNovel Peptide Ligands of RGS4 from a Focused One-Bead, One-Compound Libraryen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pharmacology, University of Michigan, 1301 MSRB III/SPC5632, Ann Arbor, MI 48103, USAen_US
dc.contributor.affiliationumDepartment of Medicinal Chemistry, College of Pharmacy, University of Michigan, 428 Church Street, Ann Arbor, MI 48109-1065, USAen_US
dc.identifier.pmid18637987en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/65605/1/j.1747-0285.2008.00687.x.pdf
dc.identifier.doi10.1111/j.1747-0285.2008.00687.xen_US
dc.identifier.sourceChemical Biology & Drug Designen_US
dc.identifier.citedreferenceHepler J.R. ( 1999 ) Emerging roles for RGS proteins in cell signalling. Trends Pharmacol Sci ; 9 : 376 – 382.en_US
dc.identifier.citedreferenceBerman D.M., Kozasa T., Gilman A.G. ( 1996 ) The GTPase-activating protein RGS4 stabilizes the transition state for nucleotide hydrolysis. J Biol Chem ; 44 : 27209 – 27212.en_US
dc.identifier.citedreferenceWang Q., Liu M., Mullah B., Siderovski D.P., Neubig R.R. ( 2002 ) Receptor-selective effects of endogenous RGS3 and RGS5 to regulate mitogen-activated protein kinase activation in rat vascular smooth muscle cells. J Biol Chem ; 28 : 24949 – 24958.en_US
dc.identifier.citedreferenceXu X., Zeng W., Popov S., Berman D.M., Davignon I., Yu K., Yowe D., Offermanns S., Muallem S., Wilkie T.M. ( 1999 ) RGS proteins determine signaling specificity of Gq-coupled receptors. J Biol Chem ; 6 : 3549 – 3556.en_US
dc.identifier.citedreferenceHague C., Bernstein L.S., Ramineni S., Chen Z., Minneman K.P., Hepler J.R. ( 2005 ) Selective inhibition of alpha1A-adrenergic receptor signaling by RGS2 association with the receptor third intracellular loop. J Biol Chem ; 29 : 27289 – 27295.en_US
dc.identifier.citedreferenceKrumins A.M., Barker S.A., Huang C., Sunahara R.K., Yu K., Wilkie T.M., Gold S.J., Mumby S.M. ( 2004 ) Differentially regulated expression of endogenous RGS4 and RGS7. J Biol Chem ; 4 : 2593 – 2599.en_US
dc.identifier.citedreferenceGold S.J., Ni Y.G., Dohlman H.G., Nestler E.J. ( 1997 ) Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J Neurosci ; 20 : 8024 – 8037.en_US
dc.identifier.citedreferenceTraynor J.R., Neubig R.R. ( 2005 ) Regulators of G protein signaling and drugs of abuse. Mol Interv ; 1 : 30 – 41.en_US
dc.identifier.citedreferenceNeubig R.R. ( 2002 ) Regulators of G protein signaling (RGS proteins): novel central nervous system drug targets. J Pept Res ; 6 : 312 – 316.en_US
dc.identifier.citedreferenceZhong H., Neubig R.R. ( 2001 ) Regulator of G protein signaling proteins: novel multifunctional drug targets. J Pharmacol Exp Ther ; 3 : 837 – 845.en_US
dc.identifier.citedreferenceCho H., Park C., Hwang I.Y., Han S.B., Schimel D., Despres D., Kehrl J.H. ( 2008 ) Rgs5 targeting leads to chronic low blood pressure and a lean body habitus. Mol Cell Biol ; 28 : 2590 – 2597.en_US
dc.identifier.citedreferenceDing J., Guzman J.N., Tkatch T., Chen S., Goldberg J.A., Ebert P.J., Levitt P., Wilson C.J., Hamm H.E., Surmeier D.J. ( 2006 ) RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat Neurosci ; 6 : 832 – 842.en_US
dc.identifier.citedreferenceRodriguez-Munoz M., de la Torre-Madrid E., Gaitan G., Sanchez-Blazquez P., Garzon J. ( 2007 ) RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons. Cell Signal ; 12 : 2558 – 2571.en_US
dc.identifier.citedreferenceRahman Z., Schwarz J., Gold S.J., Zachariou V., Wein M.N., Choi K.H., Kovoor A. et al. ( 2003 ) RGS9 modulates dopamine signaling in the basal ganglia. Neuron ; 6 : 941 – 952.en_US
dc.identifier.citedreferenceDruey K.M. ( 2003 ) Regulators of G protein signalling: potential targets for treatment of allergic inflammatory diseases such as asthma. Expert Opin Ther Targets ; 4 : 475 – 484.en_US
dc.identifier.citedreferenceUsui I., Imamura T., Satoh H., Huang J., Babendure J.L., Hupfeld C.J., Olefsky J.M. ( 2004 ) GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation. EMBO J ; 14 : 2821 – 2829.en_US
dc.identifier.citedreferenceHuang X., Charbeneau R.A., Fu Y., Kaur K., Gerin I., MacDougald O.A., Neubig R.R. ( 2008 ) Resistance to diet-induced obesity and improved insulin sensitivity in mice with a regulator of G protein signaling-insensitive G184S Gnai2 allele. Diabetes ; 1 : 77 – 85.en_US
dc.identifier.citedreferenceHeo K., Ha S.H., Chae Y.C., Lee S., Oh Y.S., Kim Y.H., Kim S.H., Kim J.H., Mizoguchi A., Itoh T.J., Kwon H.M., Ryu S.H., Suh P.G. ( 2006 ) RGS2 promotes formation of neurites by stimulating microtubule polymerization. Cell Signal ; 12 : 2182 – 2192.en_US
dc.identifier.citedreferenceBoss C.N., Grunebach F., Brauer K., Hantschel M., Mirakaj V., Weinschenk T., Stevanovic S., Rammensee H.G., Brossart P. ( 2007 ) Identification and characterization of T-cell epitopes deduced from RGS5, a novel broadly expressed tumor antigen. Clin Cancer Res ; 11 : 3347 – 3355.en_US
dc.identifier.citedreferenceAbramow-Newerly M., Roy A.A., Nunn C., Chidiac P. ( 2006 ) RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. Cell Signal ; 5 : 579 – 591.en_US
dc.identifier.citedreferenceBernstein L.S., Grillo A.A., Loranger S.S., Linder M.E. ( 2000 ) RGS4 binds to membranes through an amphipathic alpha-helix. J Biol Chem ; 24 : 18520 – 18526.en_US
dc.identifier.citedreferenceBernstein L.S., Ramineni S., Hague C., Cladman W., Chidiac P., Levey A.I., Hepler J.R. ( 2004 ) RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11alpha signaling. J Biol Chem ; 20 : 21248 – 21256.en_US
dc.identifier.citedreferenceGu S., He J., Ho W.T., Ramineni S., Thal D.M., Natesh R., Tesmer J.J., Hepler J.R., Heximer S.P. ( 2007 ) Unique hydrophobic extension of the RGS2 amphipathic helix domain imparts increased plasma membrane binding and function relative to other RGS R4/B subfamily members. J Biol Chem ; 45 : 33064 – 33075.en_US
dc.identifier.citedreferenceJin Y., Zhong H., Omnaas J.R., Neubig R.R., Mosberg H.I. ( 2004 ) Structure-based design, synthesis, and pharmacologic evaluation tf peptide RGS4 inhibitors. J Pept Res ; 2 : 141 – 146.en_US
dc.identifier.citedreferenceTesmer J.J., Berman D.M., Gilman A.G., Sprang S.R. ( 1997 ) Structure of RGS4 bound to AlF4-activated G(i alpha1): stabilization of the transition state for GTP hydrolysis. Cell ; 2 : 251 – 261.en_US
dc.identifier.citedreferenceRoof R.A., Jin Y., Roman D.L., Sunahara R.K., Ishii M., Mosberg H.I., Neubig R.R. ( 2006 ) Mechanism of action and structural requirements of constrained peptide inhibitors of RGS proteins. Chem Biol Drug Des ; 4 : 266 – 274.en_US
dc.identifier.citedreferenceJameson E.E., Roof R.A., Whorton M.R., Mosberg H.I., Sunahara R.K., Neubig R.R., Kennedy R.T. ( 2005 ) Real-time detection of basal and stimulated G protein GTPase activity using fluorescent GTP analogues. J Biol Chem ; 9 : 7712 – 7719.en_US
dc.identifier.citedreferenceLam K.S., Salmon S.E., Hersh E.M., Hruby V.J., Kazmierski W.M., Knapp R.J. ( 1991 ) A new type of synthetic peptide library for identifying ligand-binding activity. Nature ; 6348 : 82 – 84.en_US
dc.identifier.citedreferenceLan K.L., Sarvazyan N.A., Taussig R., Mackenzie R.G., DiBello P.R., Dohlman H.G., Neubig R.R. ( 1998 ) A point mutation in Galphao and Galphai1 blocks interaction with regulator of G protein signaling proteins. J Biol Chem ; 21 : 12794 – 12797.en_US
dc.identifier.citedreferenceLan K.L., Zhong H., Nanamori M., Neubig R.R. ( 2000 ) Rapid kinetics of regulator of G-protein signaling (RGS)-mediated Galphai and Galphao deactivation. Galpha specificity of RGS4 AND RGS7. J Biol Chem ; 43 : 33497 – 33503.en_US
dc.identifier.citedreferenceLee E., Linder M.E., Gilman A.G. ( 1994 ) Expression of G-protein alpha subunits in Escherichia coli. Methods Enzymol ; 237 : 146 – 164.en_US
dc.identifier.citedreferenceRoman D.L., Talbot J.N., Roof R.A., Sunahara R.K., Traynor J.R., Neubig R.R. ( 2007 ) Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay. Mol Pharmacol ; 1 : 169 – 175.en_US
dc.identifier.citedreferenceCabilly S. ( 1998 ) Combinatorial Peptide Library Protocols. Totowa, NJ : Humana Press.en_US
dc.identifier.citedreferenceOlivos H.J., Bachhawat-Sikder K., Kodadek T. ( 2003 ) Quantum dots as a visual aid for screening bead-bound combinatorial libraries. Chembiochem ; 11 : 1242 – 1245.en_US
dc.identifier.citedreferenceKimple A.J., Willard F.S., Giguere P.M., Johnston C.A., Mocanu V., Siderovski D.P. ( 2007 ) The RGS protein inhibitor CCG-4986 is a covalent modifier of the RGS4 Galpha-interaction face. Biochem Biophys Acta ; 9 : 1213 – 1220.en_US
dc.identifier.citedreferenceWhitty A., Kumaravel G. ( 2006 ) Between a rock and a hard place? Nat Chem Biol ; 3 : 112 – 118.en_US
dc.identifier.citedreferenceFry D.C., Vassilev L.T. ( 2005 ) Targeting protein–protein interactions for cancer therapy. J Mol Med ; 12 : 955 – 963.en_US
dc.identifier.citedreferenceScott J.K., Huang S.F., Gangadhar B.P., Samoriski G.M., Clapp P., Gross R.A., Taussig R., Smrcka A.V. ( 2001 ) Evidence that a protein–protein interaction ‘hot spot’ on heterotrimeric G protein betagamma subunits is used for recognition of a subclass of effectors. EMBO J ; 4 : 767 – 776.en_US
dc.identifier.citedreferenceTrosset J.Y., Dalvit C., Knapp S., Fasolini M., Veronesi M., Mantegani S., Gianellini L.M., Catana C., Sundstrom M., Stouten P.F., Moll J.K. ( 2006 ) Inhibition of protein–protein interactions: the discovery of druglike beta-catenin inhibitors by combining virtual and biophysical screening. Proteins ; 1 : 60 – 67.en_US
dc.identifier.citedreferenceThanos C.D., DeLano W.L., Wells J.A. ( 2006 ) Hot-spot mimicry of a cytokine receptor by a small molecule. Proc Natl Acad Sci USA ; 42 : 15422 – 15427.en_US
dc.identifier.citedreferenceWells J.A., McClendon C.L. ( 2007 ) Reaching for high-hanging fruit in drug discovery at protein–protein interfaces. Nature ; 7172 : 1001 – 1009.en_US
dc.identifier.citedreferenceYoung K.H., Wang Y., Bender C., Ajit S., Ramirez F., Gilbert A., Nieuwenhuijsen B.W. ( 2004 ) Yeast-based screening for inhibitors of RGS proteins. Methods Enzymol ; 389 : 277 – 301.en_US
dc.identifier.citedreferenceIshii M., Fujita S., Yamada M., Hosaka Y., Kurachi Y. ( 2005 ) Phosphatidylinositol 3,4,5-trisphosphate and Ca2+/calmodulin competitively bind to the regulators of G-protein-signalling (RGS) domain of RGS4 and reciprocally regulate its action. Biochem J ; 385 : 65 – 73.en_US
dc.identifier.citedreferenceFear G., Komarnytsky S., Raskin I. ( 2007 ) Protease inhibitors and their peptidomimetic derivatives as potential drugs. Pharmacol Ther ; 2 : 354 – 368.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1747-0285.2008.00687.x.pdf
Size:
369.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.